Trials / Withdrawn
WithdrawnNCT01022983
Preoperative Levosimendan and Heart Failure
Preoperative Levosimendan in Patients With Heart Failure Undergoing Elective Noncardiac Surgery: A Randomized, Placebocontrolled Trial. SIMPLE Study
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Sykehuset i Vestfold HF · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the safety and efficacy of Levosimendan given preoperative to patients with heart failure undergoing noncardiac surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levosimendan | At least 2 hours before surgery: Infusion of Levosimendan (0,1 microgram/kg/min.). 24 hours of infusion without a bolus. |
| DRUG | Placebo | ml/kg/hours - same infusion rate as active comparator |
Timeline
- Start date
- 2011-04-01
- Primary completion
- 2012-12-01
- Completion
- 2012-12-01
- First posted
- 2009-12-01
- Last updated
- 2012-12-17
Locations
4 sites across 2 countries: Norway, Sweden
Source: ClinicalTrials.gov record NCT01022983. Inclusion in this directory is not an endorsement.